EU: EUDAMED actor registration module active as of December 2020
With the MDR, EUDAMED will act as central repository of information to lay the foundation for collaboration, transparency and interaction of all parties, namely the new European databank for medical devices and in vitro diagnostic devices.
EUDAMED will have several modules and contain extensive data. The data will allow access to all stakeholders including the European Commission, NCAs, Notified Bodies, MAID, Sponsors and the public.
Registration will be open to Economic Operators starting in December 2020
Do you know how to register for EUDAMED?
Contact Meditrial to learn everything you need to know on how to prepare! With us, you will be the first to comply.
Read Meditrial’s whitepaper to learn more on the MDR and Eudamed.
Sign up to Meditrial Academy course offerings to find free training and opportunities for professional certification.
Contact Meditrial for immediate assistance in Europe or the US.
Free Helpline +1-800-901-4286
Table of Contents
Build a Defensible Clinical Evidence Strategy Under EU MDR
Build a defensible clinical evidence strategy under MDR Annex XIV, from the clinical evaluation plan to PMCF and notified body review.
Getting a CE mark for medical devices: a step-by-step guide
Practical guidance on the CE mark for medical devices under EU MDR, from classification and evidence to conformity assessment and EUDAMED
A Practical RBQM Framework for Medical Device Trials
Risk-based quality management for medical device trials, with practical actions for risk assessment, monitoring, data review, and trial oversight
EU Breakthrough Medical Devices Under MDCG 2025-9 (BtX)
EU breakthrough medical devices gain a clearer regulatory pathway under MDCG 2025-9, with early advice and lifecycle evidence planning
What Swissmedic Fast-Track Means for Clinical Trial Sponsors
Swissmedic swissethics Fast-Track Pilot Project accelerates eligible trial reviews and makes coordinated regulatory preparation increasingly important.
FDA Breakthrough Device Acceleration
How innovative MedTech companies can accelerate FDA approval, secure Medicare coverage, and reach patients faster—starting with Breakthrough Device Designation.
This article provides general information and does not constitute regulatory or legal advice. Requirements should be confirmed for the specific study, applicable regulatory framework, and markets concerned.
